DaVita Inc. Commences Exchange Offer
DaVita Inc. announced today that it has commenced an offer to exchange (the "Exchange Offer") up to $500,000,000 of its 6-5/8% Senior Notes due 2013, registered under the Securities Act of 1933,...
DaVita Inc. announced today that it has commenced an offer to exchange (the "Exchange Offer") up to $500,000,000 of its 6-5/8% Senior Notes due 2013, registered under the Securities Act of 1933,...
DaVita Inc. , announced today that DaVita and Gambro Healthcare, Inc. have entered into a definitive agreement with RenalAmerica, Inc. to sell 70 freestanding renal dialysis centers to...
DaVita Inc. , today announced results for the quarter ended June 30, 2005. Net income for the three months and six months ended June 30, 2005 was $52.9 million and $109.3 million, or $0.51 and...
DaVita Inc. announced that The Centers for Medicare & Medicaid Services (CMS) has selected RMS Disease Management, LLC, a wholly-owned subsidiary of DaVita, to operate a three-year demonstration...
DaVita Inc. announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 28, 2005; at 11:30 am EDT. The Company plans to release its results...